To develop a biosimilar medicine, it is noteworthy that we comprehend all the main characteristics of the reference drug. Once entering a human body, it is important to understand how the medication responds biologically and physico-chemically, and how the medicine works when it recognizes target cells. 

Since biologics are made from living cells, there are of course minor differences from batch to batch. We provide a large quantity of the reference medicine to fully understand the reference medicine that may have batch-to-batch variations.

Therefore, at PouraGen, we use the latest Hight-Tech Analytical equipment to examine the Critical Quality Attributes (CQAs) of our products.